Vitruvia Medical Past Earnings Performance

Past criteria checks 0/6

Vitruvia Medical has been growing earnings at an average annual rate of 47.9%, while the Life Sciences industry saw earnings growing at 13.9% annually. Revenues have been declining at an average rate of 48.7% per year.

Key information

47.9%

Earnings growth rate

34.1%

EPS growth rate

Life Sciences Industry Growth26.8%
Revenue growth rate-48.7%
Return on equityn/a
Net Margin-30.5%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Vitruvia Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

MUN:991 Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 232-110
30 Sep 232-120
30 Jun 232-220
31 Mar 232-220
31 Dec 222-120
30 Jun 221-700
31 Mar 222-710
31 Dec 212-820
31 Dec 206-230

Quality Earnings: 991 is currently unprofitable.

Growing Profit Margin: 991 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if 991's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare 991's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 991 is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-0.7%).


Return on Equity

High ROE: 991's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies